StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Down 0.2 % Shares of NASDAQ ABIO opened at $2.01 on Monday. The firm has a market cap of […]